AzTrials
AzTrials

Diabetes Mellitus, Type 2NCT04416841

Tai Chi Chuan as Rehabilitation Program for Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients

A study testing Tai Chi Chuan, Fitness Walking and Standard Diabetic Care Education in people with Diabetes Mellitus, Type 2 and Cognitive Dysfunction, run by Jing Tao at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The patients with type 2 diabetes mellitus (T2DM) is expected to rise to 439 million in 2030, accounting for 7.7% the population in the world. There are nearly 10 million T2DM patients with mild cognitive impairment (MCI) among people over 65 years old , accounting for about 8% of the people over 65 years old in… Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
Tai Chi Chuan, Fitness Walking and Standard Diabetic Care Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
328 participants
Where
1 siteChina
Study dates
3 Jun 2020to 20 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • clinician diagnosis of T2DM;
  • presence of mild cognitive impairment, not demented;
  • age ≥ 60 years old;
  • did not engage in regular exercise in the last three months (at least 3 times a week, at least 20 minutes of regular exercise each time);
  • informed consent and voluntary participation.

Who cannot join

  • cognitive impairment caused by other reasons, taking drugs, poisoning, etc;
  • presence of medical conditions that unable or unsafe to exercise, such as depression symptoms, uncontrolled hypertension/ blood pressure/ blood glucose, nervous system diseases(stroke, Parkinson's disease, etc), musculoskeletal system diseases(arthritis, history of hip and/or knee joint replacement, etc), etc;
  • participating in other experiments that influence this study.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Fujian University of Traditional Chinese Medicine

    Fuzhou, Fujian, 350122

Other trials in China

About this study

Official title: Efficacy of Tai Chi Chuan on Cognitive Function in Type 2 Diabetes Mellitus Patients Accompanied With Mild Cognitive Impairment

The patients with type 2 diabetes mellitus (T2DM) is expected to rise to 439 million in 2030, accounting for 7.7% the population in the world. There are nearly 10 million T2DM patients with mild cognitive impairment (MCI) among people over 65 years old , accounting for about 8% of the people over 65 years old in China. The medical cost for patients with T2DM/MCI is 2.5 to 4 times higher than those without T2DM. And T2DM will increase the risk of cognitive impairment, and lead to various complications which will bring serious social and medical economic burden.

Read the detailed description

It is critically important to identify effective treatments to enhance functional status of T2DM/MCI patients. Exercise has been shown to be beneficial for T2DM/MCI patients. As a Chinese traditional mind-body exercise that consists of both physical and mediation components, Tai Chi Chuan has been proved to be helpful in global cognition, memory, executive function and attention of MCI, and blood sugar of T2DM. However, the evidence of the effect of Tai Chi Chuan on T2DM/MCI patients is limited. The purpose of this study is to explore the effect of Tai Chi Chuan treating T2DM/MCI patients in cognitive function, balance, motor and sensation function, blood sugar, biochemistry profile and quality of life.

Being tested
Tai Chi Chuan, Fitness Walking, Standard Diabetic Care Education
Keywords
Tai Chi Chuan, Cognitive Function, Postural Balance
Medical subject headings
Diabetes Mellitus, Type 2, Cognitive Dysfunction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tai Chi ChuanBehavioural

    Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training. Besides, they would also take standard diabetic care education 0.5hour/session, 2 sessions/month for 6 months.

  • Fitness WalkingBehavioural

    Participants would take fitness walking training 1 hour/session, 3sessions/week for 24 weeks. There were 10 minutes warm-up, 40 minutes fitness walking and 10 minutes cool-down exercises in the fitness walking training, the exercise intensity was 50% to 70% of the maximum heart rate. Besides, they would also take standard diabetic care education 0.5hour/session, 2 sessions/month for 6 months.

  • Standard Diabetic Care EducationBehavioural

    Participants would take standard diabetic care education 0.5hour/session, 2 sessions/month for 6 months.

Study groups in NCT04416841
Study groupRoleWhat they receive
Tai Chi Chuan GroupExperimentalIn addition to conventional medical treatment, participants will receive 3 sessions of 1-hour Tai Chi Chuan training per week for 24 weeks and standard diabetic care education.
Receives: Behavioral: Tai Chi Chuan
Fitness Walking GroupActive comparatorIn addition to conventional medical treatment, participants will receive 3 sessions of 1-hour fitness walking training per week for 24 weeks and standard diabetic care education
Receives: Behavioral: Fitness Walking
Control groupOtherIn addition to conventional medical treatment, participants will receive standard diabetic care education 0.5hour/session, 2 sessions/month for 6 months.
Receives: Behavioral: Standard Diabetic Care Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Global cognition-Montreal Cognitive Assessment at 36 Weeks

    Montreal Cognitive Assessment

    Measured: 36 weeks (post-intervention follow-up)

Secondary outcomes (15)
  1. Global cognition-Montreal Cognitive Assessment at 24 weeks

    Montreal Cognitive Assessment

    Measured: 24 weeks (post-intervention)

  2. Memory function-Wechsler Memory Scale at 24, 36 Weeks

    Wechsler Memory Scale

    Measured: 24, 36 weeks

  3. Digital Symbol test at 24, 36 weeks

    Digital Symbol test

    Measured: 24, 36 weeks

  4. Trial Making Test part B at 24, 36 weeks

    Trial Making Test part B

    Measured: 24, 36 weeks

  5. Stroop color word test at 24, 36 weeks

    Stroop color word test

    Measured: 24, 36 weeks

  6. Boston naming test at 24, 36 weeks

    Boston naming test

    Measured: 24, 36 weeks

  7. Rey-Osterrieth complex graphics test at 24, 36 weeks

    Rey-Osterrieth complex graphics test

    Measured: 24, 36 weeks

  8. Multi-task balance test: Time up and go test; Time up and go test + cognitive task;Time up and go test + motor task;Time up and go test + cognitive task + motor task at 24, 36 weeks

    Time up and go test; Time up and go test + cognitive task (animal naming); Time up and go test + motor task (holding a cup of water); Time up and go test + cognitive task + motor task.

    Measured: 24, 36 weeks

  9. Functional reach test at 24, 36 weeks

    Functional reach test

    Measured: 24, 36 weeks

  10. One leg stance test at 24, 36 weeks

    One leg stance test

    Measured: 24, 36 weeks

  11. Grip strength at 24, 36 weeks

    Grip strength

    Measured: 24, 36 weeks

  12. Five times sit-to-stand test at 24, 36 weeks

    Five times sit-to-stand test

    Measured: 24, 36 weeks

  13. Sensation function at 24, 36 weeks

    Tactile sensation; Two-point discrimination sensation; Vibration sensation.

    Measured: 24, 36 weeks

  14. Fall efficiency-Modified Falls Efficacy Scale at 24, 36 weeks

    Modified Falls Efficacy Scale

    Measured: 24, 36 weeks

  15. Quality of life-Medical Outcomes Study 36-item Short-Form Health Survey at 24, 36 weeks

    Medical Outcomes Study 36-item Short-Form Health Survey (SF-36)

    Measured: 24, 36 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2020
  2. Study start3 Jun 2020
  3. Primary completion15 Mar 2022
  4. Study completion20 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
328 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04416841
Sponsor's protocol ID
FujianUTCM
Status last verified
Sep 2022
First submitted
26 May 2020
Last updated
22 Sep 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • You Y, Liu Z, Chen Y, Xu Y, Qin J, Guo S, Huang J, Tao J. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Acta Diabetol. 2021 Jun;58(6):671-685. doi: 10.1007/s00592-020-01648-9. Epub 2021 Jan 8.

    PubMed 33417039
  • Qin J, Chen Y, Guo S, You Y, Xu Y, Wu J, Liu Z, Huang J, Chen L, Tao J. Effect of Tai Chi on Quality of Life, Body Mass Index, and Waist-Hip Ratio in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021 Jan 19;11:543627. doi: 10.3389/fendo.2020.543627. eCollection 2020.

    PubMed 33542702
  • Guo S, Xu Y, Qin J, Chen Y, You Y, Tao J, Liu Z, Huang J. Effect of tai chi on glycaemic control, lipid metabolism and body composition in adults with type 2 diabetes: A meta-analysis and systematic review. J Rehabil Med. 2021 Mar 22;53(3):jrm00165. doi: 10.2340/16501977-2799.

    PubMed 33594445
  • Bai A, Tao L, Huang J, Tao J, Liu J. Effects of physical activity on cognitive function among patients with diabetes in China: a nationally longitudinal study. BMC Public Health. 2021 Mar 11;21(1):481. doi: 10.1186/s12889-021-10537-x.

    PubMed 33706749
  • Yin L, Qin J, Chen Y, Xie J, Hong C, Huang J, Xu Y, Liu Z, Tao J. Impact of Body Mass Index on Static Postural Control in Adults With and Without Diabetes: A Cross-Sectional Study. Front Endocrinol (Lausanne). 2021 Dec 24;12:768185. doi: 10.3389/fendo.2021.768185. eCollection 2021.

    PubMed 35002958
  • Xie J, Yin L, Huang J, Xu Y, Chen Y, Qin J, Liu Z, Tao J. Correlation between impaired hemodynamic response and cardiopulmonary fitness in middle-aged type 2 diabetes mellitus patients: a case-control study. Eur J Appl Physiol. 2022 Oct;122(10):2295-2303. doi: 10.1007/s00421-022-05008-z. Epub 2022 Jul 20.

    PubMed 35859047
  • Chen Y, Qin J, Tao L, Liu Z, Huang J, Liu W, Xu Y, Tang Q, Liu Y, Chen Z, Chen S, Liang S, Chen C, Xie J, Liu J, Chen L, Tao J. Effects of Tai Chi Chuan on Cognitive Function in Adults 60 Years or Older With Type 2 Diabetes and Mild Cognitive Impairment in China: A Randomized Clinical Trial. JAMA Netw Open. 2023 Apr 3;6(4):e237004. doi: 10.1001/jamanetworkopen.2023.7004.

    PubMed 37022680

Questions about this trial

What is this clinical trial studying?

A study testing Tai Chi Chuan, Fitness Walking and Standard Diabetic Care Education in people with Diabetes Mellitus, Type 2 and Cognitive Dysfunction, run by Jing Tao at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Global cognition-Montreal Cognitive Assessment at 36 Weeks (time frame: 36 weeks (post-intervention follow-up)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04416841, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in